Opportunities and challenges with comprehensive genomic profiling: the right solution for the right question
sponsored by Thermo Fisher Scientific
March 11, 2021, 8am PST | 11am EST | 4pm GMT
Comprehensive genomic profiling (CGP) is advancing precision oncology research through simultaneous analysis of multiple biomarkers in a single next-generation sequencing (NGS) assay.
In this webinar, our speakers will discuss the benefits of CGP and how this technique is utilized in their lab. They will share their evaluation of the Oncomine Comprehensive Assay Plus for detection of both single-gene and multi-gene biomarkers, as well as hot emerging biomarkers such as homologous recombination repair deficiency (HRD).
Webinar Learning Objectives:
- Outline the benefits of comprehensive genomic profiling and when samples should be profiled with this technique in clinical research
- Introduce new features in enhanced Oncomine Comprehensive Assay Plus
- Define homologous recombination repair deficiency (HRD), its importance as an emerging biomarker, and value in CGP